Search
Menu
Lumencor Inc. - Power of Light 4-24 LB

InfraReDx Inc.

Facebook X LinkedIn Email
InfraReDx Inc. of Burlington, Mass., has received 501(k) clearance from the FDA to market its near-infrared spectroscopic system for coronary artery examination. The corporation hopes that the catheter-based, fiber optic device, which has a laser light source, will enable cardiologists to characterize plaque composition and identify potentially rupture-prone lipid-based plaques. Recently, the company closed a $22.3 million round of funding to complete studies and finalize product development in preparation for a 2007 launch of the device.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: January 2007
    BiophotonicsFDAInfraReDx Inc.near-infrared spectroscopic systemNews & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.